IPOs
By The Online Investor Staff, updated Sat., Mar. 30, 2:05 AM
Slide #2. Boundless Bio, Inc. — Initial Public Offering
Company: |
Boundless Bio, Inc. |
Proposed Symbol: |
BOLD |
Shares Offered: |
6,250,000 |
Price Per Share: |
$16.00 |
Over-Allotment: |
937,500 |
Description: |
Boundless Bio, Inc. (NASDAQ:BOLD), a clinical stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at an initial public offering price of $16.00 per share. All of the shares are being offered by Boundless Bio. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $100.0 million. Boundless Bio's common stock is expected to begin trading on the Nasdaq Global Select Market on March 28, 2024 under the ticker symbol "BOLD." The offering is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions. In addition, Boundless Bio has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. |
IPOs: Boundless Bio, Inc.
|
March 30, 2024 2:05 AM Eastern
|